$VNDA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Vanda Pharmaceuticals Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Vanda Pharmaceuticals Inc.. Get notifications about new insider transactions in Vanda Pharmaceuticals Inc. for free.

Page:   1 2 3 4 5 ... 8 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 09 2021VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS18.00175,0003,150,0531,221,0621.4 M to 1.2 M (-12.54 %)
Mar 08 2021VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS17.855,40096,39086,92692.3 K to 86.9 K (-5.85 %)
Mar 08 2021VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS17.882003,57692,32692.5 K to 92.3 K (-0.22 %)
Feb 26 2021VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...Option ExerciseA20.2877,5001,571,70077,500
Feb 26 2021VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...GrantA0.0032,7000112,05679.4 K to 112.1 K (+41.21 %)
Feb 18 2021VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseM7.1115,000106,6500
Feb 18 2021VNDAVanda Pharmaceutic ...Watkins ThomasDirectorSellS18.545,818107,85649,50555.3 K to 49.5 K (-10.52 %)
Feb 18 2021VNDAVanda Pharmaceutic ...Watkins ThomasDirectorBuyM7.1115,000106,65055,32340.3 K to 55.3 K (+37.20 %)
Feb 18 2021VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseM7.1115,000106,6500
Feb 18 2021VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorSellS18.545,754106,66354,88760.6 K to 54.9 K (-9.49 %)
Feb 18 2021VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorBuyM7.1115,000106,65060,64145.6 K to 60.6 K (+32.87 %)
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM8.7546,663408,3010
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM8.7561,520538,30046,663
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM8.7541,817365,899108,183
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS13.0039,150508,8441,303,7471.3 M to 1.3 M (-2.92 %)
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM8.7546,663408,3011,342,8971.3 M to 1.3 M (+3.60 %)
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS13.1951,049673,3061,296,2341.3 M to 1.3 M (-3.79 %)
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM8.7561,520538,3001,347,2831.3 M to 1.3 M (+4.78 %)
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS12.8835,053451,3601,285,7631.3 M to 1.3 M (-2.65 %)
Dec 15 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM8.7541,817365,8991,320,8161.3 M to 1.3 M (+3.27 %)
Aug 21 2020VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...SellS11.083,71041,10956,29060 K to 56.3 K (-6.18 %)
Aug 17 2020VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS11.813,68443,52679,35683 K to 79.4 K (-4.44 %)
Aug 17 2020VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS11.813,68443,52679,35683 K to 79.4 K (-4.44 %)
Aug 14 2020VNDAVanda Pharmaceutic ...Jones Aranthan IIChief Corp. Affairs ...SellS11.817,20085,01875,48782.7 K to 75.5 K (-8.71 %)
Jul 29 2020VNDAVanda Pharmaceutic ...Moran Kevin PatrickSVP, CFO & Treasure ...Option ExerciseA10.8390,000974,70090,000
Jul 29 2020VNDAVanda Pharmaceutic ...Moran Kevin PatrickSVP, CFO & Treasure ...GrantA0.0017,344078,09760.8 K to 78.1 K (+28.55 %)
Jul 29 2020VNDAVanda Pharmaceutic ...Jones Aranthan IIChief Corp. Affairs ...SellS10.627,31377,63182,68790 K to 82.7 K (-8.13 %)
Jun 15 2020VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseA10.5710,000105,70010,000
Jun 15 2020VNDAVanda Pharmaceutic ...Watkins ThomasDirectorGrantA0.005,000040,32335.3 K to 40.3 K (+14.16 %)
Jun 15 2020VNDAVanda Pharmaceutic ...Ward Anne SempowskiDirectorOption ExerciseA10.5710,000105,70010,000
Jun 15 2020VNDAVanda Pharmaceutic ...Ward Anne SempowskiDirectorGrantA0.005,00005,0000 to 5 K
Jun 15 2020VNDAVanda Pharmaceutic ...Mitchell Stephen RayDirectorOption ExerciseA10.5710,000105,70010,000
Jun 15 2020VNDAVanda Pharmaceutic ...Mitchell Stephen RayDirectorGrantA0.005,00005,200200 to 5.2 K (+2,500.00 %)
Jun 15 2020VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseA10.5710,000105,70010,000
Jun 15 2020VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorGrantA0.005,000045,64140.6 K to 45.6 K (+12.30 %)
Jun 15 2020VNDAVanda Pharmaceutic ...Chrousos PhaedraDirectorOption ExerciseA10.5710,000105,70010,000
Jun 15 2020VNDAVanda Pharmaceutic ...Chrousos PhaedraDirectorGrantA0.005,000010,0005 K to 10 K (+100.00 %)
Jun 02 2020VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseM7.3815,000110,7000
Jun 02 2020VNDAVanda Pharmaceutic ...Watkins ThomasDirectorSellS11.509,677111,28635,32345 K to 35.3 K (-21.50 %)
Jun 02 2020VNDAVanda Pharmaceutic ...Watkins ThomasDirectorBuyM7.3815,000110,70045,00030 K to 45 K (+50.00 %)
May 29 2020VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseM7.3815,000110,7000
May 29 2020VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorSellS11.0410,129111,80640,64150.8 K to 40.6 K (-19.95 %)
May 29 2020VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorBuyM7.3815,000110,70050,77035.8 K to 50.8 K (+41.93 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS10.511,23713,00483,04084.3 K to 83 K (-1.47 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS10.303,14832,43684,27787.4 K to 84.3 K (-3.60 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...SellS10.181,45014,755165,384166.8 K to 165.4 K (-0.87 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS10.985,15256,5441,278,9991.3 M to 1.3 M (-0.40 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS10.5710,428110,2111,284,1511.3 M to 1.3 M (-0.81 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...SellS10.765,88963,359186,869192.8 K to 186.9 K (-3.06 %)
Mar 04 2020VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...SellS10.1912,968132,087192,758205.7 K to 192.8 K (-6.30 %)
Feb 28 2020VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...Option ExerciseA11.3270,000792,40070,000
Feb 28 2020VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...GrantA0.0030,000087,42557.4 K to 87.4 K (+52.24 %)
Feb 28 2020VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...Option ExerciseA11.3270,000792,40070,000
Feb 28 2020VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...GrantA0.0030,000060,00030 K to 60 K (+100.00 %)
Feb 28 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseA11.32140,0001,584,800140,000
Feb 28 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOGrantA0.0060,00001,294,5791.2 M to 1.3 M (+4.86 %)
Feb 28 2020VNDAVanda Pharmaceutic ...Jones Aranthan IIChief Corp. Affairs ...Option ExerciseA11.3270,000792,40070,000
Feb 28 2020VNDAVanda Pharmaceutic ...Jones Aranthan IIChief Corp. Affairs ...GrantA0.0030,000090,00060 K to 90 K (+50.00 %)
Feb 28 2020VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...Option ExerciseA11.3270,000792,40070,000
Feb 28 2020VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...GrantA0.0030,0000177,231147.2 K to 177.2 K (+20.38 %)
Jan 06 2020VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...SellS16.061,15518,551166,834168 K to 166.8 K (-0.69 %)
Jan 06 2020VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS16.009,467151,4931,234,5791.2 M to 1.2 M (-0.76 %)
Jan 06 2020VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...SellS15.944,02064,086205,726209.7 K to 205.7 K (-1.92 %)
Jan 06 2020VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS15.934,02064,021147,231151.3 K to 147.2 K (-2.66 %)
Dec 13 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM10.6585,801913,7810
Dec 13 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM10.6589,199949,96985,801
Dec 13 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS16.9870,0361,189,3511,244,0461.3 M to 1.2 M (-5.33 %)
Dec 13 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM10.6585,801913,7811,314,0821.2 M to 1.3 M (+6.99 %)
Dec 13 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS16.9272,3731,224,3771,228,2811.3 M to 1.2 M (-5.56 %)
Dec 13 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM10.6589,199949,9691,300,6541.2 M to 1.3 M (+7.36 %)
Oct 28 2019VNDAVanda Pharmaceutic ...Ward Anne SempowskiDirectorOption ExerciseA14.2135,000497,35035,000
Oct 28 2019VNDAVanda Pharmaceutic ...Ward Anne SempowskiDirectorOption ExerciseA14.2135,000497,35035,000
Aug 28 2019VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseM14.7815,000221,7000
Aug 28 2019VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorSellS14.8515,000222,75035,77050.8 K to 35.8 K (-29.55 %)
Aug 28 2019VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorBuyM14.7815,000221,70050,77035.8 K to 50.8 K (+41.93 %)
Aug 21 2019VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...Option ExerciseA15.3390,0001,379,70090,000
Aug 21 2019VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...GrantA0.0030,000030,0000 to 30 K
Aug 21 2019VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...Option ExerciseA15.3390,0001,379,70090,000
Aug 21 2019VNDAVanda Pharmaceutic ...Wijkstrom JoakimSVP, Chief Marketin ...GrantA0.0030,000030,0000 to 30 K
Aug 15 2019VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...SellS14.692,57537,82957,42560 K to 57.4 K (-4.29 %)
Jun 17 2019VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseA15.0410,000150,40010,000
Jun 17 2019VNDAVanda Pharmaceutic ...Watkins ThomasDirectorGrantA0.005,000030,00025 K to 30 K (+20.00 %)
Jun 17 2019VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseA15.0410,000150,40010,000
Jun 17 2019VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorGrantA0.005,000035,77030.8 K to 35.8 K (+16.25 %)
Jun 17 2019VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorOption ExerciseA15.0410,000150,40010,000
Jun 17 2019VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorGrantA0.005,000015,00010 K to 15 K (+50.00 %)
Jun 17 2019VNDAVanda Pharmaceutic ...Chrousos PhaedraDirectorOption ExerciseA15.0410,000150,40010,000
Jun 17 2019VNDAVanda Pharmaceutic ...Chrousos PhaedraDirectorGrantA0.005,00005,0000 to 5 K
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM12.5579,019991,6880
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM12.5573,608923,78079,019
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM12.5597,3731,222,031152,627
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.3472,8721,117,9511,211,4551.3 M to 1.2 M (-5.67 %)
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM12.5579,019991,6881,284,3271.2 M to 1.3 M (+6.56 %)
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.1267,4181,019,0841,205,3081.3 M to 1.2 M (-5.30 %)
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM12.5573,608923,7801,272,7261.2 M to 1.3 M (+6.14 %)
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS15.5677,2251,201,6911,199,1181.3 M to 1.2 M (-6.05 %)
May 21 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOBuyM12.5597,3731,222,0311,276,3431.2 M to 1.3 M (+8.26 %)
Apr 24 2019VNDAVanda Pharmaceutic ...Chrousos PhaedraDirectorOption ExerciseA17.3135,000605,85035,000
Mar 04 2019VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...SellS19.924438,823167,989168.4 K to 168 K (-0.26 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...SellS20.174388,832168,432168.9 K to 168.4 K (-0.26 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS19.4138,166740,8021,178,9701.2 M to 1.2 M (-3.14 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS20.226,500131,4241,217,1361.2 M to 1.2 M (-0.53 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...SellS19.888,751173,961209,746218.5 K to 209.7 K (-4.01 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...SellS20.154,976100,271218,497223.5 K to 218.5 K (-2.23 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS19.898,788174,767151,251160 K to 151.3 K (-5.49 %)
Mar 04 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS20.143,74175,325160,039163.8 K to 160 K (-2.28 %)
Mar 01 2019VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseA20.6270,0001,443,40070,000
Mar 01 2019VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...GrantA0.0030,0000168,870138.9 K to 168.9 K (+21.60 %)
Mar 01 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseA20.62140,0002,886,800140,000
Mar 01 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOGrantA0.0060,00001,223,6361.2 M to 1.2 M (+5.16 %)
Mar 01 2019VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...Option ExerciseA20.6270,0001,443,40070,000
Mar 01 2019VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...GrantA0.0030,0000223,473193.5 K to 223.5 K (+15.51 %)
Mar 01 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...Option ExerciseA20.6270,0001,443,40070,000
Mar 01 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...GrantA0.0030,0000163,780133.8 K to 163.8 K (+22.42 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...SellS26.9453014,276138,870139.4 K to 138.9 K (-0.38 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...SellS26.2860015,767139,400140 K to 139.4 K (-0.43 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS26.091,61942,232133,780135.4 K to 133.8 K (-1.20 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS26.951,17031,528135,399136.6 K to 135.4 K (-0.86 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS26.303,27286,050136,569139.8 K to 136.6 K (-2.34 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS26.044,447115,8041,163,6361.2 M to 1.2 M (-0.38 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS26.933,05682,3101,168,0831.2 M to 1.2 M (-0.26 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOSellS26.327,733203,5481,171,1391.2 M to 1.2 M (-0.66 %)
Jan 04 2019VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOGiftG0.004,00001,178,8721.2 M to 1.2 M (-0.34 %)
Aug 14 2018VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...Option ExerciseA21.4590,0001,930,50090,000
Aug 14 2018VNDAVanda Pharmaceutic ...Williams TimothySVP & General Couns ...GrantA0.0030,000030,0000 to 30 K
Jun 15 2018VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorOption ExerciseA18.3010,000183,00010,000
Jun 15 2018VNDAVanda Pharmaceutic ...COLA MICHAEL FDirectorGrantA0.005,000010,0005 K to 10 K (+100.00 %)
Jun 15 2018VNDAVanda Pharmaceutic ...MILANO VINCENTDirectorOption ExerciseA18.3010,000183,00010,000
Jun 15 2018VNDAVanda Pharmaceutic ...MILANO VINCENTDirectorGrantA0.005,000010,0005 K to 10 K (+100.00 %)
Jun 15 2018VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseA18.3010,000183,00010,000
Jun 15 2018VNDAVanda Pharmaceutic ...Watkins ThomasDirectorGrantA0.005,000025,00020 K to 25 K (+25.00 %)
May 04 2018VNDAVanda Pharmaceutic ...Watkins ThomasDirectorOption ExerciseM4.9815,00074,7000
May 04 2018VNDAVanda Pharmaceutic ...Watkins ThomasDirectorBuyM4.9815,00074,70020,0005 K to 20 K (+300.00 %)
Mar 20 2018VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorOption ExerciseM4.9815,00074,7000
Mar 20 2018VNDAVanda Pharmaceutic ...DUGAN RICHARD WDirectorBuyM4.9815,00074,70025,77010.8 K to 25.8 K (+139.28 %)
Mar 02 2018VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...Option ExerciseA18.8580,0001,508,00080,000
Mar 02 2018VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...SellS18.728,532159,712199,534208.1 K to 199.5 K (-4.10 %)
Mar 02 2018VNDAVanda Pharmaceutic ...Kelly James PatrickEVP & Chief Financi ...GrantA0.0040,0000208,066168.1 K to 208.1 K (+23.80 %)
Mar 02 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...Option ExerciseA18.8570,0001,319,50070,000
Mar 02 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...SellS18.713,66068,473115,073118.7 K to 115.1 K (-3.08 %)
Mar 02 2018VNDAVanda Pharmaceutic ...Gulino Richard L.SVP, General Counse ...GrantA0.0030,0000118,73388.7 K to 118.7 K (+33.81 %)
Mar 02 2018VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...Option ExerciseA18.8570,0001,319,50070,000
Mar 02 2018VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...SellS18.728,525159,605139,841148.4 K to 139.8 K (-5.75 %)
Mar 02 2018VNDAVanda Pharmaceutic ...Birznieks GuntherSVP, Business Devel ...GrantA0.0030,0000148,366118.4 K to 148.4 K (+25.35 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseM0.007,500015,000
Jan 04 2018VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...Option ExerciseM0.0012,500025,000
Jan 04 2018VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...BuyM0.007,5000110,000102.5 K to 110 K (+7.32 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Reverberi Gian PieroSVP & Chief Commerc ...BuyM0.0012,500087,50075 K to 87.5 K (+16.67 %)
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0018,750037,500
Jan 04 2018VNDAVanda Pharmaceutic ...Polymeropoulos Mihael HristosPresident and CEOOption ExerciseM0.0012,500012,500

Page:   1 2 3 4 5 ... 8 next >

Contact us | Follow us on Twitter